Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06139289 · ClinicalTrials.gov registry record
A Review of External Ventricular Drain Placement at the Bedside Versus Operating Room
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 200
- Enrollment target
NCT06139289: Completed study, sponsored by Methodist Health System.
NCT06139289 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06139289 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
External ventricular drain (EVD) placement is a common neurosurgical procedure and provides a way to monitor intracranial pressure. EVDs are utilized in the management of a wide array of neurosurgical indications, such as subarachnoid hemorrhage, trauma, intraventricular hemorrhage, cerebrospinal fluid (CSF) leaks, and hydrocephalus.
Primary Outcome
development of best-practice recommendations for future EVD placements
Interventions
- PROCEDURE EVD placements in the OR versus the bedside.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-09-19 |
| Est. Completion | 2025-07-21 |
What the finished NCT06139289 record still lists
NCT06139289 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which EVD placements in the OR versus the bedside. is the first listed.
NCT06139289 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06139289 about?
NCT06139289 is a clinical study titled "A Review of External Ventricular Drain Placement at the Bedside Versus Operating Room". External ventricular drain (EVD) placement is a common neurosurgical procedure and provides a way to monitor intracranial pressure. EVDs are utilized in the management of a wide array of neurosurgical indications, such as subarachnoid hemorrhage, trauma, intraventricular hemorrhage, cerebrospinal fl...
What is the current status of trial NCT06139289?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2022-09-19. Estimated completion is 2025-07-21.
What interventions are being tested in trial NCT06139289?
The interventions under investigation include: EVD placements in the OR versus the bedside. (PROCEDURE).
Who is sponsoring clinical trial NCT06139289?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI